Reaction Details |
| Report a problem with these data |
Target | Beta-galactosidase |
---|
Ligand | BDBM50469237 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1803731 (CHEMBL4276023) |
---|
IC50 | 250±n/a nM |
---|
Citation | Front, S; Almeida, S; Zoete, V; Charollais-Thoenig, J; Gallienne, E; Marmy, C; Pilloud, V; Marti, R; Wood, T; Martin, OR; Demotz, S 4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to ?-galactosidase mutations: Improved synthesis and biological investigations. Bioorg Med Chem26:5462-5469 (2018) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-galactosidase |
---|
Name: | Beta-galactosidase |
Synonyms: | Acid beta-galactosidase | BGAL_HUMAN | ELNR1 | Elastin receptor 1 | GLB1 | Lactase |
Type: | PROTEIN |
Mol. Mass.: | 76074.43 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_215886 |
Residue: | 677 |
Sequence: | MPGFLVRILPLLLVLLLLGPTRGLRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRV
PRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVIL
RPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPV
ITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTV
DFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARG
ASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKV
PEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRT
TLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENM
GRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWA
HNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLT
LFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKR
LMPPPPQKNKDSWLDHV
|
|
|
BDBM50469237 |
---|
n/a |
---|
Name | BDBM50469237 |
Synonyms: | CHEMBL4281031 |
Type | Small organic molecule |
Emp. Form. | C7H15NO3 |
Mol. Mass. | 161.1989 |
SMILES | C[C@H]1NC[C@@H](O)[C@@H](O)[C@H]1CO |r| |
Structure |
|